Test Price
2,800 AED✅ Home Collection Available
KCNB1 Gene Early Infantile Epileptic Encephalopathy Type 26 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين KCNB1 للاعتلال الدماغي الصرعي المبكر من النوع 26 بتقنية التسلسل الجيني (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Premium Patient Journey
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Laboratory Processing (Credential: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM - 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with DHA-Licensed Specialists for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: تحليل جيني دقيق بنسبة 99.9% للكشف المبكر عن الاعتلال الدماغي الصرعي من النوع 26، مع خدمة سحب منزلي فاخرة واستشارة طبية لشرح النتائج، متوافق تماماً مع قوانين الرعاية الصحية الإماراتية.
Overview
The KCNB1 Gene Early Infantile Epileptic Encephalopathy Type 26 NGS Test is a definitive molecular diagnostic tool that identifies pathogenic variants in the KCNB1 gene, enabling precise clinical management for infants with refractory seizures and neurodevelopmental delay. يوفر هذا الاختبار تشخيصاً جينياً مبكراً لنوبات الصرع المستعصية عند الرضع. Delivered via Next-Generation Sequencing (NGS) with the highest bioinformatics pipelines, this UAE‑based service ensures 3–4 week turnaround and clinical-grade results you can trust.
| Feature | Our Test (KCNB1 NGS) | Closest Alternative (Panel/Exome) |
|---|---|---|
| Precision | 99.9% single‑gene resolution with deep coverage | Multi‑gene panel may miss deep intronic/copy‑number variants |
| Methodology | NGS (Next Generation Sequencing) with Sanger confirmation | WES/WGS; longer interpretation time and incidental findings risk |
| Speed | 3–4 weeks from sample receipt | Often 6–8 weeks for whole‑exome reporting |
Physician Insight & Safety Protocol
“As a clinician, I deeply understand the emotional burden that early infantile epileptic encephalopathy places on families. This genetic test offers a definitive molecular diagnosis that can guide precise, personalized treatment decisions. Remember that every result must be correlated with comprehensive clinical and EEG findings to provide the best care for your child.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Warning
Do not discontinue prescribed anti‑epileptic medication or alter dosing without consulting your doctor. Abrupt changes can provoke severe, life‑threatening seizures.
⚠️ Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: This test is not for asymptomatic individuals without clinical suspicion; pre‑test genetic counselling (pedigree mapping) is mandatory.
- ER Red Flags: Seek immediate emergency care if your infant experiences prolonged seizures (>5 min), respiratory distress, cyanosis, or loss of consciousness.
- Do not substitute genetic testing for acute neurological evaluation.
Patient FAQ & Clinical Guidance
Q1: What is the KCNB1 gene test used for in early infantile epileptic encephalopathy?
This test identifies pathogenic KCNB1 mutations causing early infantile epileptic encephalopathy type 26, guiding targeted therapy and prognosis. يُستخدم هذا الاختبار لتحديد الطفرات الجينية المسببة للاعتلال الدماغي الصرعي المبكر من النوع 26.
Q2: How should I prepare my child for the blood draw and genetic testing?
Pre‑ preparation includes a mandatory genetic counselling session to draw a detailed pedigree chart; no fasting is required. لا يشترط الصيام، لكن الجلسة الإرشادية الوراثية ضرورية لرسم شجرة العائلة.
Q3: How long until I receive results, and what does the process involve?
Turnaround time is 3–4 weeks from sample arrival; we provide a telephonic clinical consultation to explain the findings. تظهر النتائج خلال 3 إلى 4 أسابيع مع استشارة طبية هاتفية لشرحها.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians